Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy

Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.

Eshe Nelson
Author: Eshe Nelson

Written by

Eshe Nelson

in

Denmark, Diabetes, Drugs (Pharmaceuticals), Economic Conditions and Trends, Gross Domestic Product, Novo Nordisk A/S, Ozempic (Drug), Semaglutide (Drug)
←Oliver Anthony Music’s ‘Rich Men North of Richmond’ Stays No. 1
France To Ban Muslim Students From Wearing Abayas In Schools→

More posts

  • Vittoria Ceretti Began Vogue World 2026 in a Dazzling Valentino Haute Couture Gown—Then Returned in Custom Prada

  • Scots recall Kerr & Thomas for World Cup play-offs

  • Zach Cregger’s ‘Resident Evil’ is a thrilling ride with a mean streak

  • Every generation gives Lizzie Borden a new reason to kill

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube